Showing results (71-80 of 222) with videos related to
Sort By:
Pageof 23
BMC Cardiovascular Disorders|May 8, 2015
Telerehab III: a multi-center randomized, controlled trial investigating the long-term effectiveness of a comprehensive cardiac telerehabilitation program--rationale and study designInes Frederix, Dominique Hansen, Karin Coninx, et al.Circulation. Arrhythmia and Electrophysiology|September 19, 2015
Contact Force in Atrial Fibrillation: Role of Atrial Rhythm and Ventricular Contractions: Co-Force Atrial Fibrillation StudyAndrea Sarkozy, Dipen Shah, Johan Saenen, et al.The American Journal of Cardiology|December 27, 2005
Flow mediated dilatation and cardiac function in type 1 diabetes mellitusBharati Shivalkar, Dominique Dhondt, Inge Goovaerts, et al.Insights Into Imaging|December 7, 2015
CT imaging features of atrioventricular shunts: what the radiologist must knowSimon Nicolay, Rodrigo A Salgado, Bharati Shivalkar, et al.Journal of Biomedical Optics|January 11, 2014
Digital image correlation for full-field time-resolved assessment of arterial stiffnessAdriaan Campo, Joris Soons, Hilde Heuten, et al.Atherosclerosis|June 21, 2025
Leukocyte-shed soluble CD31 unmasks coronary disease in low-risk outliers and provides source-specific inflammatory signatures of vulnerable plaquesMarco Magnoni, Daniele Andreini, Felicita Andreotti, et al.American Heart Journal|November 24, 2019
Four-year trends in oral anticoagulant use and declining rates of ischemic stroke among 194,030 atrial fibrillation patients drawn from a sample of 12 million peopleAldo P Maggioni, Letizia Dondi, Felicita Andreotti, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 3, 2005
Interplay of platelet polymorphisms, risk factors, and von [corrected] Willebrand factor [corrected] in determining collagen-adenosine diphosphate PFA-100 results in patients with coronary artery diseaseItalo Porto, Antonio Maria Leone, Luisa Nanni, et al.Heart (British Cardiac Society)|October 16, 2007
IgA anticardiolipin antibody is associated with the extent of daily-life ischaemia in patients with chronic coronary artery diseaseIgnatios Ikonomidis, John Lekakis, Georgia Vamvakou, et al.Giornale Italiano Di Cardiologia (2006)|November 27, 2014
[Characteristics and clinical use of rivaroxaban for the treatment of atrial fibrillation and venous thromboembolism]Davide Imberti, Giancarlo Agnelli, Felicita Andreotti, et al.Pageof 23